[Oxirane, 2-(Phenoxymethyl)-, Polymer With Oxirane, Ether With 2,2',2''-Nitrilotris[Ethanol] (3:1), Diblock; Tolerance Exemption, 8953-8957 [2022-03456]
Download as PDF
Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Rules and Regulations
this preamble. EPA has made, and will
continue to make, these materials
generally available through https://
www.regulations.gov and at the EPA
Region 10 Office (please contact the
person identified in the FOR FURTHER
INFORMATION CONTACT section of this
preamble for more information).
Therefore, these materials have been
approved by EPA for removal from the
Alaska SIP, have been removed from
incorporation by reference by EPA into
that plan, are no longer federally
enforceable under sections 110 and 113
of the CAA as of the effective date of the
final rule of the EPA’s approval, and
incorporation by reference will be
removed by the Director of the Federal
Register in the next update to the SIP
compilation.1
lotter on DSK11XQN23PROD with RULES1
IV. Statutory and Executive Order
Review
Under the CAA, the Administrator is
required to approve a SIP submission
that complies with the provisions of the
CAA and applicable Federal regulations.
42 U.S.C. 7410(k); 40 CFR 52.02(a).
Thus, in reviewing SIP submissions, the
EPA’s role is to approve state choices,
provided that they meet the criteria of
the CAA. Accordingly, this action
merely approves state law as meeting
Federal requirements and does not
impose additional requirements beyond
those imposed by state law. For that
reason, this action:
• Is not a ‘‘significant regulatory
action’’ subject to review by the Office
of Management and Budget under
Executive Orders 12866 (58 FR 51735,
October 4, 1993) and 13563 (76 FR 3821,
January 21, 2011);
• Does not impose an information
collection burden under the provisions
of the Paperwork Reduction Act (44
U.S.C. 3501 et seq.);
• Is certified as not having a
significant economic impact on a
substantial number of small entities
under the Regulatory Flexibility Act (5
U.S.C. 601 et seq.);
• Does not contain any unfunded
mandate or significantly or uniquely
affect small governments, as described
in the Unfunded Mandates Reform Act
of 1995 (Pub. L. 104–4);
• Does not have federalism
implications as specified in Executive
Order 13132 (64 FR 43255, August 10,
1999);
• Is not an economically significant
regulatory action based on health or
safety risks subject to Executive Order
13045 (62 FR 19885, April 23, 1997);
1 62
FR 27968 (May 22, 1997).
VerDate Sep<11>2014
15:53 Feb 16, 2022
Jkt 256001
• Is not a significant regulatory action
subject to Executive Order 13211 (66 FR
28355, May 22, 2001);
• Is not subject to requirements of
section 12(d) of the National
Technology Transfer and Advancement
Act of 1995 (15 U.S.C. 272 note) because
application of those requirements would
be inconsistent with the Clean Air Act;
and
• Does not provide EPA with the
discretionary authority to address, as
appropriate, disproportionate human
health or environmental effects, using
practicable and legally permissible
methods, under Executive Order 12898
(59 FR 7629, February 16, 1994).
The Alaska SIP does not apply on any
Indian reservation land in or in any
other area where EPA or Indian tribe has
demonstrated that a tribe has
jurisdiction. In those areas of Indian
country, this rulemaking does not have
tribal implications as specified by
Executive Order 13175 (65 FR 67249,
November 9, 2000), nor will it impose
substantial direct costs on tribal
governments or preempt tribal law.
The Congressional Review Act, 5
U.S.C. 801 et seq., as added by the Small
Business Regulatory Enforcement
Fairness Act of 1996, generally provides
that before a rule may take effect, the
agency promulgating the rule must
submit a rule report, which includes a
copy of the rule, to each House of the
Congress and to the Comptroller General
of the United States. EPA will submit a
report containing this action and other
required information to the U.S. Senate,
the U.S. House of Representatives, and
the Comptroller General of the United
States prior to publication of the rule in
the Federal Register. A major rule
cannot take effect until 60 days after it
is published in the Federal Register.
This action is not a ‘‘major rule’’ as
defined by 5 U.S.C. 804(2).
Under section 307(b)(1) of the CAA,
petitions for judicial review of this
action must be filed in the United States
Court of Appeals for the appropriate
circuit by April 18, 2022. Filing a
petition for reconsideration by the
Administrator of this final rule does not
affect the finality of this action for the
purposes of judicial review nor does it
extend the time within which a petition
for judicial review may be filed, and
shall not postpone the effectiveness of
such rule or action. This action may not
be challenged later in proceedings to
enforce its requirements. (See section
307(b)(2)).
List of Subjects in 40 CFR Part 52
Environmental protection, Air
pollution control, Carbon monoxide,
Incorporation by reference,
PO 00000
Frm 00011
Fmt 4700
Sfmt 4700
8953
Intergovernmental relations, Lead,
Nitrogen dioxide, Ozone, Particulate
matter, Reporting and recordkeeping
requirements, Sulfur oxides, Volatile
organic compounds.
Dated: February 10, 2022.
Michelle L. Pirzadeh,
Acting Regional Administrator, Region 10.
For the reasons set forth in the
preamble, 40 CFR part 52 is amended as
follows:
PART 52—APPROVAL AND
PROMULGATION OF
IMPLEMENTATION PLANS
1. The authority citation for part 52
continues to read as follows:
■
Authority: 42 U.S.C. 7401 et seq.
Subpart C—Alaska
§ 52.70
[Amended]
2. In § 52.70, the table in paragraph (c)
is amended by removing the entry ‘‘18
AAC 50.240’’ under the heading ‘‘18
AAC 50—Article 2. Program
Administration’’.
■
[FR Doc. 2022–03303 Filed 2–16–22; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2021–0840; FRL–9416–01–
OCSPP]
[Oxirane, 2-(Phenoxymethyl)-, Polymer
With Oxirane, Ether With 2,2′,2″Nitrilotris[Ethanol] (3:1), Diblock;
Tolerance Exemption
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This regulation establishes an
exemption from the requirement of a
tolerance for residues of oxirane, 2(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock (CAS
Reg. No. 2307555–89–9), when used as
an inert ingredient in a pesticide
chemical formulation. Spring
Regulatory Sciences, on behalf of Stepan
Company, submitted a petition to EPA
under the Federal Food, Drug, and
Cosmetic Act (FFDCA), requesting an
exemption from the requirement of a
tolerance. This regulation eliminates the
need to establish a maximum
permissible level for residues of oxirane,
2-(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock on food
or feed commodities.
SUMMARY:
E:\FR\FM\17FER1.SGM
17FER1
8954
Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Rules and Regulations
This regulation is effective
February 17, 2022. Objections and
requests for hearings must be received
on or before April 18, 2022, and must
be filed in accordance with the
instructions provided in 40 CFR part
178 (see also Unit I.C. of the
SUPPLEMENTARY INFORMATION).
DATES:
The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPP–2021–0840, is
available at https://www.regulations.gov
or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket)
in the Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the OPP
Docket is (703) 305–5805.
Due to the public health concerns
related to COVID–19, the EPA Docket
Center (EPA/DC) and Reading Room is
closed to visitors with limited
exceptions. The staff continues to
provide remote customer service via
email, phone, and webform. For the
latest status information on EPA/DC
services and docket access, visit https://
www.epa.gov/dockets.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Marietta Echeverria, Registration
Division (7505P), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001; main
telephone number: (703) 305–7090;
email address: RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
lotter on DSK11XQN23PROD with RULES1
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
VerDate Sep<11>2014
15:53 Feb 16, 2022
Jkt 256001
B. How can I get electronic access to
other related information?
You may access a frequently updated
electronic version of 40 CFR part 180
through the Office of the Federal
Register’s e-CFR site at https://
www.ecfr.gov/current/title-40.
C. Can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2021–0840 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing and must be received
by the Hearing Clerk on or before April
18, 2022. Addresses for mail and hand
delivery of objections and hearing
requests are provided in 40 CFR
178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
(CBI)) for inclusion in the public docket.
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
2021–0840, by one of the following
methods.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
online instructions for submitting
comments. Do not submit electronically
any information you consider to be CBI
or other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW, Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Additional instructions on
commenting or visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/dockets.
II. Background and Statutory Findings
In the Federal Register of December
21, 2021 (86 FR 72201) (FRL–8792–06),
PO 00000
Frm 00012
Fmt 4700
Sfmt 4700
EPA issued a document pursuant to
FFDCA section 408, 21 U.S.C. 346a,
announcing the receipt of a pesticide
petition (PP IN–11646) filed by Spring
Regulatory Sciences (6620 Cypresswood
Dr., Suite 250, Spring, TX 77379), on
behalf of Stepan Company (22 W
Frontage Rd., Northfield, IL 60093). The
petition requested that 40 CFR 180.960
be amended by establishing an
exemption from the requirement of a
tolerance for residues of oxirane, 2(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock (CAS
Reg. No. 2307555–89–9). That document
included a summary of the petition
prepared by the petitioner and solicited
comments on the petitioner’s request.
The Agency did not receive any
substantive public comments.
Section 408(c)(2)(A)(i) of FFDCA
allows EPA to establish an exemption
from the requirement for a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the exemption is ‘‘safe.’’
Section 408(c)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and
use in residential settings but does not
include occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing an
exemption from the requirement of a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue . . .’’ and specifies
factors EPA is to consider in
establishing an exemption.
III. Risk Assessment and Statutory
Findings
EPA establishes exemptions from the
requirement of a tolerance only in those
cases where it can be shown that the
risks from aggregate exposure to
pesticide chemical residues under
reasonably foreseeable circumstances
will pose no appreciable risks to human
health. To determine the risks from
aggregate exposure to pesticide inert
ingredients, the Agency considers the
toxicity of the inert in conjunction with
possible exposure to residues of the
inert ingredient through food, drinking
water, and through other exposures that
occur as a result of pesticide use in
residential settings. If EPA is able to
E:\FR\FM\17FER1.SGM
17FER1
lotter on DSK11XQN23PROD with RULES1
Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Rules and Regulations
determine that a finite tolerance is not
necessary to ensure that there is a
reasonable certainty that no harm will
result from aggregate exposure to the
inert ingredient, an exemption from the
requirement of a tolerance may be
established.
Consistent with FFDCA section
408(b)(2)(D), EPA has reviewed the
available scientific data and other
relevant information in support of this
action and considered its validity,
completeness and reliability and the
relationship of this information to
human risk. EPA has also considered
available information concerning the
variability of the sensitivities of major
identifiable subgroups of consumers,
including infants and children. In the
case of certain chemical substances that
are defined as polymers, the Agency has
established a set of criteria to identify
categories of polymers expected to
present minimal or no risk. The
definition of a polymer is given in 40
CFR 723.250(b) and the exclusion
criteria for identifying these low-risk
polymers are described in 40 CFR
723.250(d). Oxirane, 2(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock (CAS
Reg. No. 2307555–89–9) conforms to the
definition of a polymer given in 40 CFR
723.250(b) and meets the following
criteria that are used to identify low-risk
polymers.
1. The polymer is not a cationic
polymer nor is it reasonably anticipated
to become a cationic polymer in a
natural aquatic environment.
2. The polymer does contain as an
integral part of its composition at least
two of the atomic elements carbon,
hydrogen, nitrogen, oxygen, silicon, and
sulfur.
3. The polymer does not contain as an
integral part of its composition, except
as impurities, any element other than
those listed in 40 CFR 723.250(d)(2)(ii).
4. The polymer is neither designed
nor can it be reasonably anticipated to
substantially degrade, decompose, or
depolymerize: An adequate
biodegradation study (MRID 51712502)
was submitted for oxirane, 2(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock
showing lack of biodegradation (10.6%
at 28 days, 13% at 90 days).
5. The polymer is manufactured or
imported from monomers and/or
reactants that are already included on
the Toxic Substances Control Act
(TSCA) Chemical Substance Inventory
or manufactured under an applicable
TSCA section 5 exemption.
VerDate Sep<11>2014
15:53 Feb 16, 2022
Jkt 256001
8955
6. The polymer is not a water
absorbing polymer with a number
average molecular weight (MW) greater
than or equal to 10,000 daltons.
7. The polymer does not contain
certain perfluoroalkyl moieties
consisting of a CF3- or longer chain
length as listed in 40 CFR 723.250(d)(6).
Additionally, the polymer also meets
as required the following exemption
criteria specified in 40 CFR 723.250(e).
The polymer’s number average
molecular weight is greater than or
equal to 1,000 daltons and less than
10,000 daltons (5483 daltons). Also, the
polymer contains less than 2%
oligomeric material below MW 500
(2.0%) and less than 5% oligomeric
material below MW 1,000 (3.5%).
Thus, Oxirane, 2-(phenoxymethyl)-,
polymer with oxirane, ether with
2,2′,2″-nitrilotris[ethanol] (3:1), diblock
(CAS Reg. No. 2307555–89–9) meets the
criteria for a polymer to be considered
low risk under 40 CFR 723.250. Based
on its conformance to the criteria in this
unit, no mammalian toxicity is
anticipated from dietary, inhalation, or
dermal exposure to oxirane, 2(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock.
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
EPA has not found oxirane, 2(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock to
share a common mechanism of toxicity
with any other substances, and oxirane,
2-(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock does
not appear to produce a toxic metabolite
produced by other substances. For the
purposes of this tolerance action,
therefore, EPA has assumed that
oxirane, 2-(phenoxymethyl)-, polymer
with oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock does
not have a common mechanism of
toxicity with other substances. For
information regarding EPA’s efforts to
determine which chemicals have a
common mechanism of toxicity and to
evaluate the cumulative effects of such
chemicals, see EPA’s website at https://
www.epa.gov/pesticides/cumulative.
IV. Aggregate Exposures
For the purposes of assessing
potential exposure under this
exemption, EPA considered that
oxirane, 2-(phenoxymethyl)-, polymer
with oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock could
be present in all raw and processed
agricultural commodities and drinking
water, and that non-occupational nondietary exposure was possible. The
minimum number average MW of
oxirane, 2-(phenoxymethyl)-, polymer
with oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock is 5,300
daltons. Generally, a polymer of this
size would be poorly absorbed through
the intact gastrointestinal tract or
through intact human skin. Since
oxirane, 2-(phenoxymethyl)-, polymer
with oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock
conforms to the criteria that identify a
low-risk polymer, there are no concerns
for risks associated with any potential
exposure scenarios that are reasonably
foreseeable. The Agency has determined
that a tolerance is not necessary to
protect the public health.
Section 408(b)(2)(C) of FFDCA
provides that EPA shall apply an
additional tenfold margin of safety for
infants and children in the case of
threshold effects to account for prenatal
and postnatal toxicity and the
completeness of the data base unless
EPA concludes that a different margin of
safety will be safe for infants and
children. Due to the expected low
toxicity of oxirane,
2-(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock, EPA
has not used a safety factor analysis to
assess the risk. For the same reasons the
additional tenfold safety factor is
unnecessary.
V. Cumulative Effects From Substances
With a Common Mechanism of Toxicity
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
VIII. Other Considerations
PO 00000
Frm 00013
Fmt 4700
Sfmt 4700
VI. Additional Safety Factor for the
Protection of Infants and Children
VII. Determination of Safety
Based on the conformance to the
criteria used to identify a low-risk
polymer, EPA concludes that there is a
reasonable certainty of no harm to the
U.S. population, including infants and
children, from aggregate exposure to
residues of oxirane,
2-(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock.
A. Analytical Enforcement Methodology
An analytical method is not required
for enforcement purposes since the
Agency is establishing an exemption
E:\FR\FM\17FER1.SGM
17FER1
8956
Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Rules and Regulations
from the requirement of a tolerance
without any numerical limitation.
B. International Residue Limits
In making its tolerance decisions, EPA
seeks to harmonize U.S. tolerances with
international standards whenever
possible, consistent with U.S. food
safety standards and agricultural
practices. EPA considers the
international maximum residue limits
(MRLs) established by the Codex
Alimentarius Commission (Codex), as
required by FFDCA section 408(b)(4).
The Codex Alimentarius is a joint
United Nations Food and Agriculture
Organization/World Health
Organization food standards program,
and it is recognized as an international
food safety standards-setting
organization in trade agreements to
which the United States is a party. EPA
may establish a tolerance that is
different from a Codex MRL; however,
FFDCA section 408(b)(4) requires that
EPA explain the reasons for departing
from the Codex level.
The Codex has not established a MRL
for oxirane, 2-(phenoxymethyl)-,
polymer with oxirane, ether with
2,2′,2″-nitrilotris[ethanol] (3:1), diblock.
IX. Conclusion
Accordingly, EPA finds that
exempting residues of oxirane, 2(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock from
the requirement of a tolerance will be
safe.
X. Statutory and Executive Order
Reviews
This action establishes a tolerance
under FFDCA section 408(d) in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled ‘‘Regulatory
Planning and Review’’ (58 FR 51735,
October 4, 1993). Because this action
has been exempted from review under
Executive Order 12866, this action is
not subject to Executive Order 13211,
entitled ‘‘Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use’’ (66
FR 28355, May 22, 2001) or Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997). This action does not
contain any information collections
subject to OMB approval under the
Paperwork Reduction Act (PRA) (44
U.S.C. 3501 et seq.), nor does it require
any special considerations under
Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerance in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers,
food processors, food handlers, and food
retailers, not States or Tribes, nor does
this action alter the relationships or
distribution of power and
responsibilities established by Congress
in the preemption provisions of FFDCA
section 408(n)(4). As such, the Agency
has determined that this action will not
have a substantial direct effect on States
or Tribal Governments, on the
relationship between the National
Government and the States or Tribal
Governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
Tribes. Thus, the Agency has
determined that Executive Order 13132,
entitled ‘‘Federalism’’ (64 FR 43255,
August 10, 1999) and Executive Order
13175, entitled ‘‘Consultation and
Coordination with Indian Tribal
Governments’’ (65 FR 67249, November
9, 2000) do not apply to this action. In
addition, this action does not impose
any enforceable duty or contain any
unfunded mandate as described under
Title II of the Unfunded Mandates
Reform Act (UMRA) (2 U.S.C. 1501 et
seq.).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act
(NTTAA) (15 U.S.C. 272 note).
XI. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: February 8, 2022.
Marietta Echeverria,
Acting Director, Registration Division, Office
of Pesticide Programs.
Therefore, for the reasons stated in the
preamble, EPA is amending 40 CFR
chapter I as follows:
PART 180—TOLERANCES AND
EXEMPTIONS FOR PESTICIDE
CHEMICAL RESIDUES IN FOOD
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. In § 180.960, amend Table 1 to
§ 180.960, by adding in alphabetical
order the polymer ‘‘Oxirane, 2(phenoxymethyl)-, polymer with
oxirane, ether with 2,2′,2″nitrilotris[ethanol] (3:1), diblock,
minimum number average molecular
weight (in amu), 5,300’’ to read as
follows:
■
§ 180.960 Polymers; exemptions from the
requirement of a tolerance.
*
*
*
*
*
TABLE 1 TO § 180.960
lotter on DSK11XQN23PROD with RULES1
Polymer
CAS No.
*
*
*
*
*
*
Oxirane, 2-(phenoxymethyl)-, polymer with oxirane, ether with 2,2′,2″-nitrilotris[ethanol] (3:1), diblock, minimum number average molecular weight (in amu), 5,300 ...........................................................................................................................................
*
VerDate Sep<11>2014
*
15:53 Feb 16, 2022
*
Jkt 256001
PO 00000
*
Frm 00014
Fmt 4700
*
Sfmt 4700
E:\FR\FM\17FER1.SGM
*
17FER1
*
2307555–89–9
*
Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Rules and Regulations
[FR Doc. 2022–03456 Filed 2–16–22; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
45 CFR Part 5b
[Docket Number NIH–2016–0002]
RIN 0925–AA62
Privacy Act; Implementation
Department of Health and
Human Services.
ACTION: Final rule.
AGENCY:
The Department of Health and
Human Services (HHS or Department) is
issuing this final rule to make effective
the exemptions that were previously
proposed for a subset of records covered
in a new Privacy Act system of records,
No. 09–25–0165, NIH Loan Repayment
Records, which is maintained by the
National Institutes of Health (NIH). The
system of records covers records used to
manage and evaluate the Loan
Repayment Programs (LRPs) at NIH. The
exemptions are necessary to maintain
the integrity of the NIH peer review and
award processes by enabling NIH to
protect the identities of reviewers.
DATES: This final rule is effective
February 17, 2022.
FOR FURTHER INFORMATION CONTACT:
Dustin Close, Office of Management
Assessment, National Institutes of
Health, 6705 Rockledge Drive, Suite
601, Bethesda, Maryland 20892,
telephone 301–402–6469, email
privacy@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The NIH
Loan Repayment Programs (LRPs) are
administered by the Division of Loan
Repayment (DLR) within NIH’s Office of
Extramural Research. DLR provides
repayment of student loans for approved
applicants to encourage outstanding
health professionals to pursue careers in
biomedical, behavioral, social, and
clinical research. Research health
professionals who owe qualified
educational debt and who meet
eligibility criteria may apply for student
loan repayment. A peer review process
recommends applicants for loan
repayments. The peer review process is
committee-based, with a peer review
group comprised of individual
reviewers, referees, or other
recommenders (hereafter collectively
referred to as Reviewers). Reviewers are
primarily non-government experts
qualified by training and experience in
scientific or technical fields, or as
authorities knowledgeable in disciplines
lotter on DSK11XQN23PROD with RULES1
SUMMARY:
VerDate Sep<11>2014
15:53 Feb 16, 2022
Jkt 256001
and fields related to the areas under
review. Reviewers give DLR expert
recommendations and materials (such
as ratings, summaries, and
communications) about applicants’
suitability, eligibility, or qualifications
for student loan repayments under
express promises that the Reviewers
will not be identified as the sources of
the information. DLR uses the
information solely for the purpose of
determining applicants’ suitability,
eligibility, or qualifications for Federal
loan repayment. System of records 09–
25–0165 covers records about health
professionals who apply for student
loan repayments and about other
categories of individuals who are related
to the applications. These records
include material that could reveal the
identity of the Reviewers either directly
or indirectly.
Under the Privacy Act of 1974, as
amended (Privacy Act, 5 U.S.C. 552a, or
‘‘Privacy Act’’), individuals have a right
of access to records about themselves in
Federal agency systems of records, and
other rights with respect to those
records (such as notification,
amendment, and an accounting of
disclosures), but the Act permits certain
types of systems of records (identified in
section 552a(j) and (k)) to be exempted
from certain requirements of the Act.
Subsection (k)(5) permits the head of an
agency to promulgate rules to exempt
from the requirements in subsections
(c)(3) and (d)(1) through (4) of the Act
investigatory material compiled solely
for the purpose of determining
suitability, eligibility, or qualifications
for Federal contracts, to the extent that
the disclosure of such material would
reveal the identity of a source who
furnished information to the Federal
Government under an express promise
that the identity of the source would be
held in confidence.
In accordance with the Privacy Act,
HHS/NIH proposed to exempt material
that would identify a confidential
source in system of records 09–25–0165
from the notification, access, and
amendment requirements of the Act
pursuant to subsection (k)(5) of the Act,
as described in a notice of proposed
rulemaking (NPRM) published in the
Federal Register (86 FR 2633) for public
comment on January 13, 2021. The
agency also published a modified notice
describing system of records 09–25–
0165 (SORN) in the Federal Register (86
FR 2677) for public comment the same
day. The 60-day public comment period
provided for both the SORN and the
NRPM expired March 15, 2021. Thirteen
comments were received on the NPRM
and no comments were received on the
SORN. The comments received
PO 00000
Frm 00015
Fmt 4700
Sfmt 4700
8957
applauded NIH’s efforts to exempt
material that would identify Reviewers
contained within the system of records
as specified in the notice. Additionally,
none of the commentors recommended
any changes to the proposed exemptions
or the SORN. Therefore, HHS/NIH has
made no changes to the proposed
exemptions in the NPRM or to the
SORN.
NIH believes the exemptions are
necessary to maintain the integrity of
the NIH peer review and award
processes. Protecting Reviewer
identities as the sources of the
information they provide protects them
from harassment, intimidation, and
other attempts to improperly influence
award outcomes, and ensures that they
are not reluctant to provide sensitive
information or frank assessments. Case
law has held that exemptions
promulgated under subsection (k)(5)
may protect source-identifying material
even where the identity of the source is
known. Therefore, NIH solicits
Reviewers to assess applicants for loan
repayment programs under an express
promise of confidentiality.
The specific rationales that support
the exemptions concerning each
affected Privacy Act provision, are as
follows:
• Subsection (c)(3). An exemption
from the requirement to provide an
accounting of disclosures to record
subjects is needed to protect the identity
of any Reviewer who is expressly
promised confidentiality. Providing an
accounting of disclosures to an
applicant could identify specific
Reviewers as sources of
recommendations or evaluative input
received, or to be received, on the
application. Inappropriately revealing
the Reviewers’ identities in association
with the nature and scope of their
assessments or evaluations could lead
them to alter or destroy their
assessments or evaluations or subject
them to harassment, intimidation, or
other improper influence, which would
impede or compromise the fairness and
objectivity of the loan repayment
application review process; constitute
an unwarranted invasion of the personal
privacy of the Reviewer; and violate the
express promise of confidentiality made
to the Reviewer.
• Subsection (d)(1). An exemption
from the access requirement is needed
both during and after an application
review proceeding to avoid
inappropriately revealing the identity of
the Reviewers. Protecting the Reviewers’
identities from access by record subjects
is necessary to maintain the integrity of
the review process. It ensures Reviewers
provide candid assessments or
E:\FR\FM\17FER1.SGM
17FER1
Agencies
[Federal Register Volume 87, Number 33 (Thursday, February 17, 2022)]
[Rules and Regulations]
[Pages 8953-8957]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03456]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2021-0840; FRL-9416-01-OCSPP]
[Oxirane, 2-(Phenoxymethyl)-, Polymer With Oxirane, Ether With
2,2',2''-Nitrilotris[Ethanol] (3:1), Diblock; Tolerance Exemption
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes an exemption from the requirement
of a tolerance for residues of oxirane, 2-(phenoxymethyl)-, polymer
with oxirane, ether with 2,2',2''-nitrilotris[ethanol] (3:1), diblock
(CAS Reg. No. 2307555-89-9), when used as an inert ingredient in a
pesticide chemical formulation. Spring Regulatory Sciences, on behalf
of Stepan Company, submitted a petition to EPA under the Federal Food,
Drug, and Cosmetic Act (FFDCA), requesting an exemption from the
requirement of a tolerance. This regulation eliminates the need to
establish a maximum permissible level for residues of oxirane, 2-
(phenoxymethyl)-, polymer with oxirane, ether with 2,2',2''-
nitrilotris[ethanol] (3:1), diblock on food or feed commodities.
[[Page 8954]]
DATES: This regulation is effective February 17, 2022. Objections and
requests for hearings must be received on or before April 18, 2022, and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2021-0840, is available at
https://www.regulations.gov or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket) in the Environmental Protection
Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg.,
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC 20460-0001. The
Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is (202) 566-1744, and the telephone number for the OPP
Docket is (703) 305-5805.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is closed to visitors with
limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Marietta Echeverria, Registration
Division (7505P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; main telephone number: (703) 305-7090; email address:
[email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of 40 CFR
part 180 through the Office of the Federal Register's e-CFR site at
https://www.ecfr.gov/current/title-40.
C. Can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2021-0840 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing and must be received by the Hearing Clerk on or before
April 18, 2022. Addresses for mail and hand delivery of objections and
hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2021-0840, by one of
the following methods.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
II. Background and Statutory Findings
In the Federal Register of December 21, 2021 (86 FR 72201) (FRL-
8792-06), EPA issued a document pursuant to FFDCA section 408, 21
U.S.C. 346a, announcing the receipt of a pesticide petition (PP IN-
11646) filed by Spring Regulatory Sciences (6620 Cypresswood Dr., Suite
250, Spring, TX 77379), on behalf of Stepan Company (22 W Frontage Rd.,
Northfield, IL 60093). The petition requested that 40 CFR 180.960 be
amended by establishing an exemption from the requirement of a
tolerance for residues of oxirane, 2-(phenoxymethyl)-, polymer with
oxirane, ether with 2,2',2''-nitrilotris[ethanol] (3:1), diblock (CAS
Reg. No. 2307555-89-9). That document included a summary of the
petition prepared by the petitioner and solicited comments on the
petitioner's request. The Agency did not receive any substantive public
comments.
Section 408(c)(2)(A)(i) of FFDCA allows EPA to establish an
exemption from the requirement for a tolerance (the legal limit for a
pesticide chemical residue in or on a food) only if EPA determines that
the exemption is ``safe.'' Section 408(c)(2)(A)(ii) of FFDCA defines
``safe'' to mean that ``there is a reasonable certainty that no harm
will result from aggregate exposure to the pesticide chemical residue,
including all anticipated dietary exposures and all other exposures for
which there is reliable information.'' This includes exposure through
drinking water and use in residential settings but does not include
occupational exposure. Section 408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure of infants and children to the
pesticide chemical residue in establishing an exemption from the
requirement of a tolerance and to ``ensure that there is a reasonable
certainty that no harm will result to infants and children from
aggregate exposure to the pesticide chemical residue . . .'' and
specifies factors EPA is to consider in establishing an exemption.
III. Risk Assessment and Statutory Findings
EPA establishes exemptions from the requirement of a tolerance only
in those cases where it can be shown that the risks from aggregate
exposure to pesticide chemical residues under reasonably foreseeable
circumstances will pose no appreciable risks to human health. To
determine the risks from aggregate exposure to pesticide inert
ingredients, the Agency considers the toxicity of the inert in
conjunction with possible exposure to residues of the inert ingredient
through food, drinking water, and through other exposures that occur as
a result of pesticide use in residential settings. If EPA is able to
[[Page 8955]]
determine that a finite tolerance is not necessary to ensure that there
is a reasonable certainty that no harm will result from aggregate
exposure to the inert ingredient, an exemption from the requirement of
a tolerance may be established.
Consistent with FFDCA section 408(b)(2)(D), EPA has reviewed the
available scientific data and other relevant information in support of
this action and considered its validity, completeness and reliability
and the relationship of this information to human risk. EPA has also
considered available information concerning the variability of the
sensitivities of major identifiable subgroups of consumers, including
infants and children. In the case of certain chemical substances that
are defined as polymers, the Agency has established a set of criteria
to identify categories of polymers expected to present minimal or no
risk. The definition of a polymer is given in 40 CFR 723.250(b) and the
exclusion criteria for identifying these low-risk polymers are
described in 40 CFR 723.250(d). Oxirane, 2-(phenoxymethyl)-, polymer
with oxirane, ether with 2,2',2''-nitrilotris[ethanol] (3:1), diblock
(CAS Reg. No. 2307555-89-9) conforms to the definition of a polymer
given in 40 CFR 723.250(b) and meets the following criteria that are
used to identify low-risk polymers.
1. The polymer is not a cationic polymer nor is it reasonably
anticipated to become a cationic polymer in a natural aquatic
environment.
2. The polymer does contain as an integral part of its composition
at least two of the atomic elements carbon, hydrogen, nitrogen, oxygen,
silicon, and sulfur.
3. The polymer does not contain as an integral part of its
composition, except as impurities, any element other than those listed
in 40 CFR 723.250(d)(2)(ii).
4. The polymer is neither designed nor can it be reasonably
anticipated to substantially degrade, decompose, or depolymerize: An
adequate biodegradation study (MRID 51712502) was submitted for
oxirane, 2-(phenoxymethyl)-, polymer with oxirane, ether with 2,2',2''-
nitrilotris[ethanol] (3:1), diblock showing lack of biodegradation
(10.6% at 28 days, 13% at 90 days).
5. The polymer is manufactured or imported from monomers and/or
reactants that are already included on the Toxic Substances Control Act
(TSCA) Chemical Substance Inventory or manufactured under an applicable
TSCA section 5 exemption.
6. The polymer is not a water absorbing polymer with a number
average molecular weight (MW) greater than or equal to 10,000 daltons.
7. The polymer does not contain certain perfluoroalkyl moieties
consisting of a CF3- or longer chain length as listed in 40 CFR
723.250(d)(6).
Additionally, the polymer also meets as required the following
exemption criteria specified in 40 CFR 723.250(e).
The polymer's number average molecular weight is greater than or
equal to 1,000 daltons and less than 10,000 daltons (5483 daltons).
Also, the polymer contains less than 2% oligomeric material below MW
500 (2.0%) and less than 5% oligomeric material below MW 1,000 (3.5%).
Thus, Oxirane, 2-(phenoxymethyl)-, polymer with oxirane, ether with
2,2',2''-nitrilotris[ethanol] (3:1), diblock (CAS Reg. No. 2307555-89-
9) meets the criteria for a polymer to be considered low risk under 40
CFR 723.250. Based on its conformance to the criteria in this unit, no
mammalian toxicity is anticipated from dietary, inhalation, or dermal
exposure to oxirane, 2-(phenoxymethyl)-, polymer with oxirane, ether
with 2,2',2''-nitrilotris[ethanol] (3:1), diblock.
IV. Aggregate Exposures
For the purposes of assessing potential exposure under this
exemption, EPA considered that oxirane, 2-(phenoxymethyl)-, polymer
with oxirane, ether with 2,2',2''-nitrilotris[ethanol] (3:1), diblock
could be present in all raw and processed agricultural commodities and
drinking water, and that non-occupational non-dietary exposure was
possible. The minimum number average MW of oxirane, 2-(phenoxymethyl)-,
polymer with oxirane, ether with 2,2',2''-nitrilotris[ethanol] (3:1),
diblock is 5,300 daltons. Generally, a polymer of this size would be
poorly absorbed through the intact gastrointestinal tract or through
intact human skin. Since oxirane, 2-(phenoxymethyl)-, polymer with
oxirane, ether with 2,2',2''-nitrilotris[ethanol] (3:1), diblock
conforms to the criteria that identify a low-risk polymer, there are no
concerns for risks associated with any potential exposure scenarios
that are reasonably foreseeable. The Agency has determined that a
tolerance is not necessary to protect the public health.
V. Cumulative Effects From Substances With a Common Mechanism of
Toxicity
Section 408(b)(2)(D)(v) of FFDCA requires that, when considering
whether to establish, modify, or revoke a tolerance, the Agency
consider ``available information'' concerning the cumulative effects of
a particular pesticide's residues and ``other substances that have a
common mechanism of toxicity.''
EPA has not found oxirane, 2-(phenoxymethyl)-, polymer with
oxirane, ether with 2,2',2''-nitrilotris[ethanol] (3:1), diblock to
share a common mechanism of toxicity with any other substances, and
oxirane, 2-(phenoxymethyl)-, polymer with oxirane, ether with 2,2',2''-
nitrilotris[ethanol] (3:1), diblock does not appear to produce a toxic
metabolite produced by other substances. For the purposes of this
tolerance action, therefore, EPA has assumed that oxirane, 2-
(phenoxymethyl)-, polymer with oxirane, ether with 2,2',2''-
nitrilotris[ethanol] (3:1), diblock does not have a common mechanism of
toxicity with other substances. For information regarding EPA's efforts
to determine which chemicals have a common mechanism of toxicity and to
evaluate the cumulative effects of such chemicals, see EPA's website at
https://www.epa.gov/pesticides/cumulative.
VI. Additional Safety Factor for the Protection of Infants and Children
Section 408(b)(2)(C) of FFDCA provides that EPA shall apply an
additional tenfold margin of safety for infants and children in the
case of threshold effects to account for prenatal and postnatal
toxicity and the completeness of the data base unless EPA concludes
that a different margin of safety will be safe for infants and
children. Due to the expected low toxicity of oxirane, 2-
(phenoxymethyl)-, polymer with oxirane, ether with 2,2',2''-
nitrilotris[ethanol] (3:1), diblock, EPA has not used a safety factor
analysis to assess the risk. For the same reasons the additional
tenfold safety factor is unnecessary.
VII. Determination of Safety
Based on the conformance to the criteria used to identify a low-
risk polymer, EPA concludes that there is a reasonable certainty of no
harm to the U.S. population, including infants and children, from
aggregate exposure to residues of oxirane, 2-(phenoxymethyl)-, polymer
with oxirane, ether with 2,2',2''-nitrilotris[ethanol] (3:1), diblock.
VIII. Other Considerations
A. Analytical Enforcement Methodology
An analytical method is not required for enforcement purposes since
the Agency is establishing an exemption
[[Page 8956]]
from the requirement of a tolerance without any numerical limitation.
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4). The Codex Alimentarius is a joint United Nations
Food and Agriculture Organization/World Health Organization food
standards program, and it is recognized as an international food safety
standards-setting organization in trade agreements to which the United
States is a party. EPA may establish a tolerance that is different from
a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain
the reasons for departing from the Codex level.
The Codex has not established a MRL for oxirane, 2-(phenoxymethyl)-
, polymer with oxirane, ether with 2,2',2''-nitrilotris[ethanol] (3:1),
diblock.
IX. Conclusion
Accordingly, EPA finds that exempting residues of oxirane, 2-
(phenoxymethyl)-, polymer with oxirane, ether with 2,2',2''-
nitrilotris[ethanol] (3:1), diblock from the requirement of a tolerance
will be safe.
X. Statutory and Executive Order Reviews
This action establishes a tolerance under FFDCA section 408(d) in
response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993). Because this action has been
exempted from review under Executive Order 12866, this action is not
subject to Executive Order 13211, entitled ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997). This action does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA) (44 U.S.C. 3501 et seq.), nor does it require any
special considerations under Executive Order 12898, entitled ``Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerance in this
final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers, food processors, food
handlers, and food retailers, not States or Tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
Tribal Governments, on the relationship between the National Government
and the States or Tribal Governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian Tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000) do not apply to this action. In addition, this
action does not impose any enforceable duty or contain any unfunded
mandate as described under Title II of the Unfunded Mandates Reform Act
(UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
XI. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: February 8, 2022.
Marietta Echeverria,
Acting Director, Registration Division, Office of Pesticide Programs.
Therefore, for the reasons stated in the preamble, EPA is amending
40 CFR chapter I as follows:
PART 180--TOLERANCES AND EXEMPTIONS FOR PESTICIDE CHEMICAL RESIDUES
IN FOOD
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. In Sec. 180.960, amend Table 1 to Sec. 180.960, by adding in
alphabetical order the polymer ``Oxirane, 2-(phenoxymethyl)-, polymer
with oxirane, ether with 2,2',2''-nitrilotris[ethanol] (3:1), diblock,
minimum number average molecular weight (in amu), 5,300'' to read as
follows:
Sec. 180.960 Polymers; exemptions from the requirement of a
tolerance.
* * * * *
Table 1 to Sec. 180.960
------------------------------------------------------------------------
Polymer CAS No.
------------------------------------------------------------------------
* * * * * * *
Oxirane, 2-(phenoxymethyl)-, polymer with oxirane, 2307555-89-9
ether with 2,2',2''-nitrilotris[ethanol] (3:1),
diblock, minimum number average molecular weight (in
amu), 5,300...........................................
* * * * * * *
------------------------------------------------------------------------
[[Page 8957]]
[FR Doc. 2022-03456 Filed 2-16-22; 8:45 am]
BILLING CODE 6560-50-P